Dr. Stephanie Charleville Levenson Slocum, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1531 Hunt Club Blvd, Gallatin, TN 37066 Phone: 615-230-1600 |
Mr. Robert D. Phillips, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 437 E Main St, Gallatin, TN 37066 Phone: 615-452-8705 Fax: 615-452-8740 |
Dr. Raegan Ann Marie Diller, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 437 E Main St, Gallatin, TN 37066 Phone: 615-452-8705 Fax: 615-452-8740 |
Nancy Z Bradbury, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 1531 Hunt Club Blvd, 100, Gallatin, TN 37066 Phone: 615-230-1600 Fax: 615-230-1630 |
Eamon Avery Felton, M.D. Obstetrics & Gynecology - Gynecology Medicare: Accepting Medicare Assignments Practice Location: 437 E Main St, Gallatin, TN 37066 Phone: 615-452-8705 Fax: 615-452-8706 |
Mr. Richard Alan Bennett, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 437 E Main St, Gallatin, TN 37066 Phone: 615-452-8705 Fax: 615-452-8740 |
News Archive
The U.S. Food and Drug Administration today issued two comprehensive evaluations containing recommendations that address three key objectives of the agency's public health mission as it relates to medical devices – foster device innovation, create a more predictable regulatory environment, and enhance device safety.
The degradation of proteins and other macromolecules in cells is vital to survival. Disruption of this process can result in serious disease. The research group of Professor Thomas Jentsch (Leibniz Institute for Molecular Pharmacology, FMP/ Max Delbr-ck Center for Molecular Medicine, MDC, Berlin-Buch) has now succeeded in identifying an essential cellular process necessary for the transport and degradation of macromolecules in endosomes and lysosomes, respectively.
The Lupus Foundation of America, Inc. (LFA) congratulates Insoo Kang, M.D., Associate Professor of Medicine, Yale University for being selected to receive a $1.2 million research grant from the U.S. Department of Defense's (DoD) Congressionally Directed Peer Reviewed Medical Research Program (PRMRP). The DoD award will fund a three-year study that will investigate whether and why lupus patients make more of the chemical interleukin (IL-27), which causes decreased generation of T cells and is known to play an important role in autoimmunity and lupus.
Scientists at Brunel University London have found a way of targeting hard-to-reach cancers and degenerative diseases using nanoparticles, but without causing the damaging side effects the treatment normally brings.
› Verified 9 days ago